Want to join the conversation?
$TUP narrowed its FY16 GAAP EPS guidance to range of $4.20-4.25 from previous forecast of $4.18-4.28 and its adjusted EPS outlook to range of $4.30-4.35 from prior estimate of $4.25-4.35. Tax rate is estimated at 27.6% on a U.S. GAAP basis and 25.5% excluding items for FY16.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.